Emerging trends in the epidemiology of invasive group B streptococcal disease in England and Wales, 1991-2010

Clinical Infectious Diseases

Volumn 57, Issue 5, 2013, Pages 682-688

  Lamagni, Theresa L ^a   Keshishian, Catherine ^a   Efstratiou, Androulla ^a   Guy, Rebecca ^a   Henderson, Katherine L ^a   Broughton, Karen ^a   Sheridan, Elizabeth ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

drug resistance; epidemiology; streptococcal infections; Streptococcus agalactiae; United Kingdom

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MENINGITIS; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD CULTURE; CEREBROSPINAL FLUID; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; GROUP B STREPTOCOCCAL INFECTION; HUMAN; INCIDENCE; INFANT; INFANT DISEASE; JOINT; LIVE BIRTH; LOWER RESPIRATORY TRACT; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PERICARDIUM; PLEURA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEASONAL VARIATION; SEROTYPE; SEROTYPING; TREND STUDY; UNITED KINGDOM;

DRUG RESISTANCE; EPIDEMIOLOGY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; ENGLAND; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; RISK FACTORS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; WALES; YOUNG ADULT;

EID: 84881453559     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit337     Document Type: Article

References (33)

1. Muller-Pebody B, Johnson AP, Heath PT, Gilbert RE, Henderson KL, Sharland M. Empirical treatment of neonatal sepsis: Are the current guidelines adequate?. Arch Dis Child Fetal Neonatal Ed 2011; 96:F4-8.
2. Depani SJ, Ladhani S, Heath PT, et al. The contribution of infections to neonatal deaths in England and Wales. Pediatr Infect Dis J 2011; 30:345-7.
3. Melin P. Neonatal group B streptococcal disease: From pathogenesis to preventive strategies. Clin Microbiol Infect 2011; 17:1294-303.
4. Phares CR, Lynfield R, Farley MM, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008; 299:2056-65.
5. Skoff TH, Farley MM, Petit S, et al. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis 2009; 49:85-92.
6. Tyrrell GJ, Senzilet LD, Spika JS, et al. Invasive disease due to group B streptococcal infection in adults: Results from a Canadian, population-based, active laboratory surveillance study - 1996. Sentinel Health Unit Surveillance System Site Coordinators. J Infect Dis 2000; 182:168-73.
7. Henning KJ, Hall EL, Dwyer DM, et al. Invasive group B streptococcal disease in Maryland nursing home residents. J Infect Dis 2001; 183:1138-42.
8. Dahl MS, Tessin I, Trollfors B. Invasive group B streptococcal infections in Sweden: Incidence, predisposing factors and prognosis. Int J Infect Dis 2003; 7:113-9.
9. Health Protection Agency. Laboratory reporting. Available at: Http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/Surveillance/ SourcesOfSurveillanceData/survLaboratoryReporting/. Accessed 22 April 2013.
10. Health Protection Agency . Lancefield group B Streptococci (GBS, Streptococcus agalactiae). Available at: Http://www.hpa.org.uk/ProductsServices/ MicrobiologyPathology/LaboratoriesAndReferenceFacilities/RespiratoryAnd SystemicInfectionLaboratory/StreptococcusDiphtheriaReferenceUnit/cfi- rsil-LancefieldB/. Accessed 22 April 2013.
11. Afshar B, Broughton K, Creti R, et al. International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (group B streptococci). J Clin Microbiol 2011; 49:1475-82.
12. Simpson EH. Measurement of diversity. Nature 1949; 163:688.
13. Hasseltvedt V, Høiby EA. Systemic streptococcal group B disease in Norway - an increasing health problem. Euro Surveill 2001; 5. pii:2086.
14. Gonzalez EL, Johansson S, Wallander MA, Rodriguez LA. Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. J Epidemiol Community Health 2009; 63:332-6.
15. Laupland KB, Ross T, Church DL, Gregson DB. Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian region. Clin Microbiol Infect 2006; 12:224-30.
16. Ekelund K, Skinhoj P, Madsen J, Konradsen HB. Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: Epidemiological and clinical aspects. Clin Microbiol Infect 2005; 11:569-76.
17. Lyytikäinen O, Nuorti JP, Halmesmaki E, et al. Invasive group B streptococcal infections in Finland: A population-based study. Emerg Infect Dis 2003; 9:469-73.
18. Skogberg K, Lyytikäinen O, Ollgren J, Nuorti JP, Ruutu P. Populationbased burden of bloodstream infections in Finland. Clin Microbiol Infect 2012; 18:E170-6.
19. Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: Systematic review and meta-analysis. Lancet 2012; 379:547-56.
20. Lawn JE, Gravett MG, Nunes TM, Rubens CE, Stanton C. Global report on preterm birth and stillbirth (1 of 7): Definitions, description of the burden and opportunities to improve data. BMC Pregnancy Childbirth 2010; 10(suppl 1):S1.
21. Trijbels-Smeulders M, de Jonge GA, Pasker-de Jong PC, et al. Epidemiology of neonatal group B streptococcal disease in the Netherlands before and after introduction of guidelines for prevention. Arch Dis Child 2007; 92:F271-6.
22. Bergseng H, Rygg M, Bevanger L, Bergh K. Invasive group B streptococcus (GBS) disease in Norway 1996-2006. Eur J Clin Microbiol Infect Dis 2008; 27:1193-9.
23. Royal College of Obstetricians and Gynaecologists (RCOG). Prevention of early onset neonatal group B streptococcal disease: Guideline no. 36. London: Guidelines and Audit Committee of the RCOG; 2003.
24. Chu YW, Tse C, Tsang GK, So DK, Fung JT, Lo JY. Invasive group B Streptococcus isolates showing reduced susceptibility to penicillin in Hong Kong. J Antimicrob Chemother 2007; 60:1407-9.
25. Hsueh PR, Teng LJ, Lee LN, Ho SW, Yang PC, Luh KT. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob Agents Chemother 2001; 45:3205-8.
26. Kimura K, Suzuki S, Wachino J, et al. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 2008; 52:2890-7.
27. Dahesh S, Hensler ME, Van Sorge NM, et al. Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics. Antimicrob Agents Chemother 2008; 52:2915-8.
28. Castor ML, Whitney CG, Como-Sabetti K, et al. Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect Dis Obstet Gynecol 2008; 2008:727505.
29. Poyart C, Reglier-Poupet H, Tazi A, et al. Invasive group B streptococcal infections in infants, France. Emerg Infect Dis 2008; 14:1647-9.
30. Manning SD, Springman AC, Lehotzky E, Lewis MA, Whittam TS, Davies HD. Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada. J Clin Microbiol 2009; 47:1143-8.
31. Tazi A, Morand PC, Reglier-Poupet H, et al. Invasive group B streptococcal infections in adults, France (2007-2010). Clin Microbiol Infect 2011; 17:1587-89.
32. Persson E, Berg S, Trollfors B, et al. Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998-2001. Clin Microbiol Infect 2004; 10:791-6.
33. Health Protection Agency. Voluntary reporting of Staphylococcus aureus bacteraemia in England, Wales and Northern Ireland, 2010. Available at: Http://www.hpa.org.uk/webw/HPAweb&Page&HPAweb AutoListName/Page/ 1191942169769. Accessed 4 September 2012.